Robert Chess - Insider Trading & Ownership
-
Entity
-
Individual
-
Summary
-
The estimated net worth of Robert Chess is at least $2.56M dollars as of June 14, 2024. Robert Chess is the Director of Twist Bioscience Corp and owns shares of Twist Bioscience Corp (TWST) stock worth about $2.24M. Robert Chess is the Director of NEKTAR THERAPEUTICS and owns shares of NEKTAR THERAPEUTICS (NKTR) stock worth about $311K.
Ownership of Robert Chess
Insider Transactions Reported by Robert Chess:
Sym |
Company |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.